MFT: ARevolutionizingGeneticTesting (G123263)

Target Name: MTFMT

NCBI ID: G123263

MFT: ARevolutionizingGeneticTesting

Mount Frequency Tuning (MFT) is a genetic testing technology based on the principle of frequency tuning, proposed by researchers at the Broad Institute in the United States. This technology uses high-throughput sequencing technology to quantitatively analyze gene expression levels in cells or tissues, helping researchers understand differences in gene expression in tissues and thereby guiding disease diagnosis and treatment.

MFT is a new type of genetic testing technology that has higher sensitivity and faster detection speed than traditional genetic testing technology. By analyzing high-throughput sequencing data, MFT can detect gene expression levels in individual cells or tissues, allowing researchers to more accurately understand differences in gene expression in tissues.

The basic principle of MFT technology is to process high-throughput sequencing signals through the frequency tuning principle to detect gene expression levels. By frequency tuning the high-throughput sequencing signal, the MFT team can obtain a new signal that is more responsive and has a higher signal-to-noise ratio than the original signal. Through this method, MFT can detect gene expression levels in individual cells or tissues, thereby providing an important basis for disease diagnosis and treatment.

MFT technology is widely used in disease diagnosis and treatment. For example, MFT can be used in the diagnosis and treatment of cancer.

Protein Name: Mitochondrial Methionyl-tRNA Formyltransferase

Functions: Methionyl-tRNA formyltransferase that formylates methionyl-tRNA in mitochondria and is crucial for translation initiation

More Common Targets